Patient's Anastrozole Compliance to Therapy (PACT) Program: Baseline Data and Patient Characteristics from a Population-Based, Randomized Study Evaluating Compliance to Aromatase Inhibitor Therapy in Postmenopausal Women with Hormone-Sensitive Early Breast Cancer

Breast care

Nadia Harbeck¹  Christine Windemuth-Kieselbach¹  Peyman Hadji¹  Silke Zaun¹  Ulrike Nitz¹  Hilde Schulte¹  Hans-Joachim Lück¹  Renate Haidinger¹  Doris Schmitt¹  Maria Blettner¹  Rolf Kreienberg¹  Christian Jackisch¹ 

[1] aBreast Center, Dept. OB&GYN, University of Munich, Ulm, Germany

关键词: Breast cancer;    Compliance;    Aromatase inhibitors;    Breast-conserving surgery;    Mastectomy;   

DOI  :  10.1159/000350777

学科分类：泌尿医学

来源: S Karger AG

【 摘 要 】

The Patient's Anastrozole Compliance to Therapy (PACT) program is a large randomized study designed to assess whether the provision of educational materials (EM) could improve compliance with aromatase inhibitor therapy in postmenopausal women with early, hormone receptor-positive breast cancer.

【 授权许可】

Unknown